Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AKBA Akebia Therapeutics, Inc.

交易中 10-20 15:00:38 EDT

0.6148

-0.0653

-9.60%

最高0.7063	最低0.6122	成交量598.60万
今开0.6800	昨收0.6801	日振幅13.84%
总市值1.70亿	流通市值1.66亿	总股本2.77亿
成交额390.47万	换手率2.22%	流通股本2.69亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AKBA","market":"US","secType":"STK","nameCN":"Akebia Therapeutics, Inc.","latestPrice":0.6148,"timestamp":1792522836514,"preClose":0.6801,"halted":0,"volume":5985968,"delay":0,"changeRate":-0.09601529186884285,"floatShares":269235552,"shares":277106245,"eps":-0.111204,"marketStatus":"交易中","change":-0.0653,"latestTime":"10-20 15:00:38 EDT","open":0.68,"high":0.7063,"low":0.6122,"amount":3904652.3137712,"amplitude":0.138362,"askPrice":0.615,"askSize":100,"bidPrice":0.6147,"bidSize":113,"shortable":3,"etf":0,"ttmEps":-0.111204,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792526400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1395288000000,"exchange":"NASDAQ","adjPreClose":0.6801,"preHourTrading":{"tag":"盘前","latestPrice":0.675,"preClose":0.6801,"latestTime":"09:10 EDT","volume":6905,"amount":4658.0204730000005,"timestamp":1792501811041,"change":-0.0051,"changeRate":-0.007499,"amplitude":0.048522},"postHourTrading":{"tag":"盘后","latestPrice":0.6821,"preClose":0.6801,"latestTime":"19:54 EDT","volume":7536,"amount":5160.6851,"timestamp":1792454074267,"change":0.002,"changeRate":0.002941,"amplitude":0.025212},"volumeRatio":0.79681,"impliedVol":2.1654,"impliedVolPercentile":0.8765},"requestUrl":"/m/hq/s/AKBA","defaultTab":"news","newsList":[{"id":"1198896792","title":"Akebia Therapeutics宣布Ebribafusp针对罕见补体介导肾病II期篮式试验首位患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1198896792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198896792?lang=zh_cn&edition=full","pubTime":"2026-09-14 20:01","pubTimestamp":1789387296,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics近日对外宣布，其候选药物Ebribafusp在针对罕见补体介导肾病的一项II期篮式试验中，已完成首位患者的给药。据了解，Ebribafusp是一种新型治疗药物，旨在应对一系列由补体系统异常激活所引发的罕见肾脏疾病。Akebia Therapeutics作为一家专注肾脏病领域的生物制药公司，一直致力于为患有严重肾病的患者带来创新疗法。随着试验的持续推进，Akebia Therapeutics表示将定期公布重要研究节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKBA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168718295","title":"Akebia Therapeutics 启动针对罕见肾病的下一代补体抑制剂 Ebribafusp 2期篮子试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1168718295","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168718295?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:01","pubTimestamp":1785758478,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics 宣布，其已启动一项名为 Ebribafusp 的下一代补体抑制剂的 2期篮子试验。该试验聚焦于罕见肾病的治疗领域，旨在探索该药物在多种适应症中的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189859439","title":"Akebia Therapeutics 宣布：中期分析显示Vafseo安全性更佳，Usrc肾脏研究停止VOICE试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1189859439","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189859439?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:12","pubTimestamp":1782821535,"startTime":"0","endTime":"0","summary":"在Akebia Therapeutics - Usrc肾脏研究进行的中期分析揭示其药物Vafseo展现出更优越的安全性特征后，该研究已决定停止其名为VOICE的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111776354","title":"Akebia Therapeutics死亡率数据：Vafseo与Esa无显著差异，分别为每百患者年8.77%与8.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111776354","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111776354?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:08","pubTimestamp":1782821324,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics公布的最新数据显示，其药物Vafseo与对照药物Esa在患者死亡率方面未显示出统计学上的显著差异。具体数值上，Vafseo组的死亡率记录为每百患者年8.77%，而Esa组则为8.78%。这一结果突显了两者在关键安全性指标上的高度相似性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514038944","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514038944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514038944?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:12","pubTimestamp":1740669173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时12分，Akebia Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.72%。其相关个股中，Ironwood医药、Optinose, Inc.、基立福涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、Quantum Biopharma Ltd.较为活跃，换手率分别为23.43%、12.19%、6.32%，振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.，振幅分别为23.11%、20.58%、20.28%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231253abdf79aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231253abdf79aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513169202","title":"Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513169202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513169202?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:26","pubTimestamp":1740162384,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时26分，Akebia Therapeutics, Inc.股票出现波动，股价大幅跳水5.50%。截至发稿，该股报1.81美元/股，成交量175.929万股，换手率0.81%，振幅7.33%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为1.31%。其相关个股中，Sunshine Biopharma Inc C/Wts 、大自然药业、Therapeuticsmd, Inc.涨幅较大，大自然药业、Therapeuticsmd, Inc.、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为4252.01%、105.48%、34.98%，振幅较大的相关个股有大自然药业、Sunshine Biopharma Inc C/Wts 、Therapeuticsmd, Inc.，振幅分别为118.46%、63.34%、62.87%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022624962baffc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022624962baffc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149384","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149384?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Akebia Therapeutics, Inc.股票出现波动，股价大幅跳水5.09%。截至发稿，该股报2.13美元/股，成交量11.9169万股，换手率0.05%，振幅1.34%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.30%。其相关个股中，脑再生科技、大自然药业、Incannex Healthcare Inc.涨幅较大，Inmed Pharmaceuticals Inc.、Painreform Ltd.、苏轩堂较为活跃，换手率分别为28.80%、4.13%、1.59%，振幅较大的相关个股有Ironwood医药、苏轩堂、Canopy Growth Corporation，振幅分别为5.13%、4.88%、4.52%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223233abc106f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223233abc106f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505024274","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505024274?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:36","pubTimestamp":1737470191,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时36分，Akebia Therapeutics, Inc.股票出现异动，股价快速拉升5.07%。截至发稿，该股报2.18美元/股，成交量47.3209万股，换手率0.22%，振幅5.80%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.68%。其相关个股中，Inmed Pharmaceuticals Inc.、Evolus, Inc. Common Stock、Im Cannabis Corp.涨幅较大，Inmed Pharmaceuticals Inc.、大自然药业、Cbdmd, Inc.较为活跃，换手率分别为1859.59%、3.15%、2.61%，振幅较大的相关个股有Akanda Corp.、Flora Growth Corp.、Amneal Pharmaceuticals, Inc.，振幅分别为105.06%、104.15%、101.94%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223631986e33ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223631986e33ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504118780","title":"Akebia Therapeutics, Inc.盘中异动 大幅拉升5.44%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504118780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504118780?lang=zh_cn&edition=full","pubTime":"2025-01-18 02:10","pubTimestamp":1737137404,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日02时10分，Akebia Therapeutics, Inc.股票出现异动，股价快速上涨5.44%。截至发稿，该股报2.04美元/股，成交量428.997万股，换手率1.97%，振幅5.70%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为1.49%。其相关个股中，Im Cannabis Corp.、Inmed Pharmaceuticals Inc.、和黄医药涨幅较大，Cbdmd, Inc.、大自然药业、Painreform Ltd.较为活跃，换手率分别为21.31%、14.10%、10.91%，振幅较大的相关个股有Cbdmd, Inc.、Alvotech C/Wts 、Aytu Biopharma, Inc.，振幅分别为21.41%、15.00%、12.44%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118021004a225ec1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118021004a225ec1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503628678","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503628678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503628678?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:03","pubTimestamp":1736953420,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时03分，Akebia Therapeutics, Inc.股票出现异动，股价急速上涨5.25%。截至发稿，该股报1.99美元/股，成交量39.8299万股，换手率0.18%，振幅3.47%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.67%。其相关个股中，Therapeuticsmd, Inc.、Alvotech C/Wts 、博美集团涨幅较大，大自然药业、Cbdmd, Inc.、Intra-Cellular Therapies Inc.较为活跃，换手率分别为16.48%、6.00%、2.33%，振幅较大的相关个股有Talphera, Inc.、坎伯兰药业、苏轩堂，振幅分别为11.86%、10.49%、9.79%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152303409867444f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152303409867444f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503501704","title":"HC Wainwright & Co.：重申Akebia Therapeutics(AKBA.US)评级，由买入调整至买入评级, 目标价由7.50美元调整至7.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503501704","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503501704?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:22","pubTimestamp":1736875351,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Akebia Therapeutics(AKBA.US)评级，由买入调整至买入评级, 目标价由7.50美元调整至7.50美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15012247459144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503858503","title":"Akebia Therapeutics, Inc.盘中异动 急速上涨5.14%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503858503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503858503?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:56","pubTimestamp":1736780184,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时56分，Akebia Therapeutics, Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报1.84美元/股，成交量64.8217万股，换手率0.30%，振幅7.14%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为1.03%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Intra-Cellular Therapies Inc.、脑再生科技涨幅较大，Intra-Cellular Therapies Inc.、大自然药业、Cbdmd, Inc.较为活跃，换手率分别为10.74%、7.82%、4.77%，振幅较大的相关个股有Citius Oncology, Inc.、正业生物、Biofrontera Inc.，振幅分别为17.39%、11.05%、9.82%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132256259864daa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132256259864daa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495030165","title":"Akebia Therapeutics, Inc.盘中异动 临近收盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495030165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495030165?lang=zh_cn&edition=full","pubTime":"2024-12-31 05:01","pubTimestamp":1735592463,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日05时01分，Akebia Therapeutics, Inc.股票出现异动，股价急速下挫5.13%。截至发稿，该股报1.85美元/股，成交量187.925万股，换手率0.86%，振幅4.62%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.92%。其相关个股中，Emergent Biosolutions Inc.、Biofrontera Inc C/Wts 27/10/2026 、Scilex Holding Company涨幅较大，大自然药业、Painreform Ltd.、苏轩堂较为活跃，换手率分别为37.39%、24.02%、14.37%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Alvotech C/Wts 、Scilex Holding Company，振幅分别为40.56%、30.96%、23.10%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231050103985570fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231050103985570fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492159353","title":"Akebia Therapeutics, Inc.盘中异动 急速下挫5.08%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492159353?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:26","pubTimestamp":1734553585,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时26分，Akebia Therapeutics, Inc.股票出现异动，股价快速跳水5.08%。截至发稿，该股报1.78美元/股，成交量193.226万股，换手率0.89%，振幅6.68%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为1.27%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Procaps Group S.A. C/Wts 29/09/2026 、坎伯兰药业涨幅较大，Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.、Painreform Ltd.较为活跃，换手率分别为69.18%、28.32%、18.89%，振幅较大的相关个股有Quantum Biopharma Ltd.、Im Cannabis Corp.、Bioage Labs, Inc.，振幅分别为53.90%、37.44%、28.05%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042625a1f95415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042625a1f95415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491356319","title":"Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491356319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491356319?lang=zh_cn&edition=full","pubTime":"2024-12-13 03:20","pubTimestamp":1734031202,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日03时20分，Akebia Therapeutics, Inc.股票出现异动，股价大幅跳水5.21%。截至发稿，该股报1.82美元/股，成交量162.762万股，换手率0.75%，振幅4.95%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为1.24%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Flora Growth Corp.、Incannex Healthcare Inc.涨幅较大，大自然药业、Flora Growth Corp.、Painreform Ltd.较为活跃，换手率分别为46.49%、18.34%、9.52%，振幅较大的相关个股有Gelteq Limited、Scilex Holding Company C/Wts 10/11/2027 、Sunshine Biopharma Inc C/Wts ，振幅分别为33.61%、26.09%、25.56%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213032002a1e9cf0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213032002a1e9cf0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490863357","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490863357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490863357?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:33","pubTimestamp":1733927593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时33分，Akebia Therapeutics, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报1.88美元/股，成交量24.5064万股，换手率0.11%，振幅3.28%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.22%。其相关个股中，Citius Oncology, Inc.、Avadel Pharmaceuticals Plc、Optinose, Inc.涨幅较大，Biofrontera Inc.、大自然药业、坎伯兰药业较为活跃，换手率分别为41.15%、7.02%、6.00%，振幅较大的相关个股有Bausch Health Companies Inc.、Biofrontera Inc.、Organogenesis Holdings Inc.，振幅分别为7.27%、5.85%、5.71%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223313ab6fcaf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223313ab6fcaf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488973850","title":"Akebia Therapeutics, Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488973850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488973850?lang=zh_cn&edition=full","pubTime":"2024-12-04 04:17","pubTimestamp":1733257071,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日04时17分，Akebia Therapeutics, Inc.股票出现异动，股价急速下挫5.16%。截至发稿，该股报2.02美元/股，成交量259.044万股，换手率1.19%，振幅6.57%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.91%。其相关个股中，Citius Oncology, Inc.、Medicus Pharma Ltd.、Sunshine Biopharma Inc C/Wts 涨幅较大，Citius Oncology, Inc.、大自然药业、Painreform Ltd.较为活跃，换手率分别为140.12%、39.18%、39.15%，振幅较大的相关个股有Citius Oncology, Inc.、Medicus Pharma Ltd.、Sunshine Biopharma Inc C/Wts ，振幅分别为116.67%、45.51%、32.53%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204041751a26a2928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204041751a26a2928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486881122","title":"Akebia Therapeutics, Inc.盘中异动 快速上涨5.18%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486881122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486881122?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:41","pubTimestamp":1732642890,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时41分，Akebia Therapeutics, Inc.股票出现波动，股价快速拉升5.18%。截至发稿，该股报2.03美元/股，成交量165.453万股，换手率0.76%，振幅6.48%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体涨幅为2.62%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc.、Biofrontera Inc.涨幅较大，Sunshine Biopharma Inc.、Painreform Ltd.、Sonoma Pharmaceuticals, Inc.较为活跃，换手率分别为52.37%、34.55%、9.05%，振幅较大的相关个股有Sunshine Biopharma Inc.、Painreform Ltd.、Biofrontera Inc.，振幅分别为29.51%、20.63%、17.39%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127014130971a8b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127014130971a8b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484548998","title":"Akebia Therapeutics, Inc.2024财年第三财季实现净利润-20.04百万美元，同比减少38.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484548998?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772998,"startTime":"0","endTime":"0","summary":"11月17日，Akebia Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-20.04百万美元，同比减少38.30%；其中营业收入为37.43百万美元，同比减少10.99%，每股基本收益为-0.10美元。机构评级：截至2024年11月17日，当前有3家机构对Akebia Therapeutics, Inc.目标价做出预测，其中目标均价为5.50美元，其中最低目标价为4.00美元，最高目标价为7.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000423a23e070a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000423a23e070a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483505838","title":"Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.28%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483505838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483505838?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:39","pubTimestamp":1731436767,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时39分，Akebia Therapeutics, Inc.股票出现波动，股价急速下挫5.28%。截至发稿，该股报1.89美元/股，成交量127.083万股，换手率0.60%，振幅5.28%。Akebia Therapeutics, Inc.股票所在的制药行业中，整体跌幅为1.10%。其相关个股中，Biofrontera Inc.、Biofrontera Inc C/Wts 27/10/2026 、Cronos Group Inc. Common Share涨幅较大，Rockwell Medical, Inc.、Sonoma Pharmaceuticals, Inc.、Canopy Growth Corporation较为活跃，换手率分别为15.92%、12.82%、10.65%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Biofrontera Inc.、Sunshine Biopharma Inc C/Wts ，振幅分别为32.37%、25.60%、24.14%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113023927971a6193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113023927971a6193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akebia.com","stockEarnings":[{"period":"1week","weight":-0.1393},{"period":"1month","weight":-0.2573},{"period":"3month","weight":-0.4768},{"period":"6month","weight":-0.5211},{"period":"1year","weight":-0.7679},{"period":"ytd","weight":-0.5776}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0243},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.1537},{"period":"ytd","weight":0.124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Akebia Therapeutics, Inc.依法于2007年2月27日在特拉华州成立。该公司是一家致力于：基于缺氧诱导因子的新型生物性专有疗法的研发，肾脏疾病患者所需产品商业化应用的生物制药公司。HIF是人体内红细胞生成和潜在贫血治疗新机制的主要调节器。Akebia的候选主导产品AKB-6548作为一种每日一次的口服产品，已经成功完成2a期概念验证。研究表明AKB-6548可以在不需要透析的情况下安全有效地提高继发性贫血和慢性肾病患者的血红蛋白水平。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.00708},{"month":2,"riseRate":0.416667,"avgChangeRate":0.050021},{"month":3,"riseRate":0.5,"avgChangeRate":-0.064082},{"month":4,"riseRate":0.461538,"avgChangeRate":0.020155},{"month":5,"riseRate":0.538462,"avgChangeRate":0.019133},{"month":6,"riseRate":0.692308,"avgChangeRate":0.059932},{"month":7,"riseRate":0.538462,"avgChangeRate":0.050176},{"month":8,"riseRate":0.307692,"avgChangeRate":-0.055764},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.052687},{"month":10,"riseRate":0.076923,"avgChangeRate":-0.128724},{"month":11,"riseRate":0.666667,"avgChangeRate":0.130076},{"month":12,"riseRate":0.5,"avgChangeRate":0.078804}],"exchange":"NASDAQ","name":"Akebia Therapeutics, Inc.","nameEN":"Akebia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Akebia Therapeutics, Inc.,AKBA,Akebia Therapeutics, Inc.股票,Akebia Therapeutics, Inc.股票老虎,Akebia Therapeutics, Inc.股票老虎国际,Akebia Therapeutics, Inc.行情,Akebia Therapeutics, Inc.股票行情,Akebia Therapeutics, Inc.股价,Akebia Therapeutics, Inc.股市,Akebia Therapeutics, Inc.股票价格,Akebia Therapeutics, Inc.股票交易,Akebia Therapeutics, Inc.股票购买,Akebia Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}